Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-17-000012
Filing Date
2017-08-10
Accepted
2017-08-10 16:42:18
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-063017x10q.htm 10-Q 950075
2 EXHIBIT 31.1 anab-063017x10qxexx311.htm EX-31.1 8088
3 EXHIBIT 31.2 anab-063017x10qxexx312.htm EX-31.2 8102
4 EXHIBIT 32.1 anab-063017x10qxexx321.htm EX-32.1 5761
5 EXHIBIT 32.2 anab-063017x10qxexx322.htm EX-32.2 5732
12 MILESTONE CHART a2017milestones8817.jpg GRAPHIC 76219
  Complete submission text file 0001370053-17-000012.txt   5134709

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anab-20170630.xml EX-101.INS 939745
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20170630.xsd EX-101.SCH 39589
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20170630_cal.xml EX-101.CAL 61323
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20170630_def.xml EX-101.DEF 226229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20170630_lab.xml EX-101.LAB 587683
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20170630_pre.xml EX-101.PRE 337719
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 171021972
SIC: 2834 Pharmaceutical Preparations